The 20 Best Urothelial Cancer Doctors Near Me in Washington, DC

Armine Smith, M.D. is the director of urologic oncology at the Kimmel Cancer Center at Sibley Memorial Hospital, and an associate clinical professor of urology at the Brady Urological Institute of Johns Hopkins University School of Medicine. She is a member of Greenberg Bladder Cancer Institute and the director of Women's Bladder Cancer Program at Sibley Memorial Hospital. She is also a Mary and Armeane Choksi Scholar. Dr. Smith earned her medical degree from the University of California in San Francisco. She completed a residency in urology at the Cleveland Clinic, followed by a fellowship in urologic oncology at the National Cancer Institute, where she focused on development of personalized targeted therapies for bladder cancer. Dr. Smith is a member of the Society of Urologic Oncology, American Association of Cancer Research and American Urological Association. She has been selected multiple times as a Washington, DC and Virginia top urologist. Dr. Smith specializes in advanced open, minimally invasive and robotic urologic surgery for urologic malignancies, including bladder and upper tract urothelial cancer, kidney cancer, testicular cancer, penile and urethral cancer. In bladder cancer surgery she specializes in bladder preservation, complex urinary diversions, including continent orthotopic neobladder and continent catheterizable Indiana pouch techniques. In kidney cancer, her expertise focuses on partial nephrectomy, with the goal of oncologically-sound maximum nephron-sparing surgery. She has contributed to various research, publications and presentations on topics of urology. Dr. Smith has made TV appearances, lectured domestically and internationally, and authored chapters on urothelial and kidney cancer. Her current research focuses on elucidation of risk factors for bladder cancer development, oncologically safe organ preservation in both men and women with bladder and kidney cancer and improving outcomes from bladder cancer treatments. Listen to Dr. Smith’s Cancer Matters podcast episode to learn more about her work. Dr. Smith is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy. Dr. Smith is board certified in American Board Of Urology.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 62 other conditions, according to our data. His clinical expertise encompasses Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Splenectomy. Dr. Kressel is board certified in American Board Of Internal Medicine.

Andrew Akman, MD, MBA a native of Washington, DC, currently practices at Suburban Hospital, Sibley Hospital, and Johns Hopkins Hospital. Dr. Akman performs a variety of minimally invasive procedures. He has specific interest in complex IVC filter removals, interventional oncology, pulmonary embolism, and prostate artery embolization. Dr. Akman is an expert in complex IVC filter retrieval and IVC filter related complications. In addition to standard IVC filter retrievals, he removes devices that are severely tilted, embedded, or fractured, as well as those designated as permanent devices. He serves as an adviser to other physicians on complex techniques including laser sheath and forceps assisted retrieval. Within interventional oncology, Dr. Akman performs thermal ablation of lung, liver, and kidney tumors. He performs chemoembolization and radioembolization (Yttrium-90) on primary liver cancer and metastatic liver disease. Dr. Akman also performs prostate artery embolization, an emerging minimally invasive technique for treating urinary symptoms associated with prostate enlargement. Dr. Akman prides himself on building strong relationships with his patients and practicing patient-centered medicine. Videos Andrew Akman, M.D., Interventional Radiologist Recent News Articles and Media Coverage Honoring a Life By Helping Others, Johns Hopkins Medicine, (July 20, 2022). Dr. Akman is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Ascites, Ureterocele, Familial Pancreatic Cancer, Gastrostomy, and Liver Embolization. Dr. Akman is board certified in American Board Of Radiology.

Dr. Thomas W. Jarrett has an expertise in minimally invasive surgery, including laparoscopic, robotic, ureteroscopic, percutaneous and image-guided therapies. Specifically, he has an expertise in percutaneous renal surgery, laparoscopic partial and radical nephrectomy, kidney stones, urinary tract reconstruction and kidney cancer. Dr. Jarrett earned his medical degree from Emory University School of Medicine, where he also completed his internship. He completed a residency in urology at New York Hospital, followed by a visiting fellowship in urology and ultrasonography in Salzburg, Austria. Dr. Jarrett completed his fellowship in endo-urology at Long Island Jewish Medical Center. He has previously served as the chief of the division of endourology and laparoscopy at the Johns Hopkins Hospital and the chief of the division of urology at Johns Hopkins Bayview Medical Center. Dr. Jarrett has been named a Top MD by Consumers’ Checkbook Magazine and a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly. He has also been named a Super Doctor by the Washington Post. Dr. Jarrett is a member of the American Urological Association, the Society of Urologic Oncology and the Endourological Society. Dr. Jarrett has contributed to various publications and presentations on urology, earning him first prize in the World Congress of Endourology essay contest and the Faculty Research Award at Long Island Jewish Medical Center. He has editorial appointments at the Journal of Endourology and the Journal of Laparoendoscopic and Advanced Surgical Techniques. Dr. Jarrett is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Ureterocele, Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Nephrectomy, and Reconstructive Urology Surgery. Dr. Jarrett is board certified in American Board Of Urology.

Wohlscheid Director, Genitourinary Oncology Research Inova Schar Cancer Dr. Jeanny B. Aragon-Ching, MD, FACP, serves as the Clinical Program Director of Genitourinary Cancers at the Inova Schar Cancer Institute with a joint academic appointment as Associate Professor of Medical Education at the University of Virginia. Dr. Aragon-Ching joined Inova Schar Cancer Institute in 2015 to spearhead the GU Oncology program and bring together multidisciplinary expertise and advancement of research, clinical trial development, and personalized clinical care of patients with GU cancers. She has since served in the ASCO GU Program Planning Committee from 2017-2019, served as Track Chair for Urothelial cancers in 2018 and Renal Cell Cancer Track in 2016–2017 and member of the Prostate cancer track. She has chaired different sessions on bladder urothelial and non-urothelial cancers, kidney and prostate cancers. She also served in the ASCO Cancer Education Committee for the annual meeting for the GU non-prostate cancers. She is dedicated to the research and clinical care of patients with genitourinary cancers. Dr. Aragon-Ching completed her internship and residency at the Albert Einstein Medical Center in Philadelphia, PA, where she served the final year as Chief Resident. She later completed a Medical Oncology Fellowship at the National Cancer Institute, National Institutes of Health, in Bethesda, MD, where she served as an Associate Investigator on varying trials involved with pharmacogenomics and early drug discovery for genitourinary tumors. Dr. Aragon-Ching later moved to the George Washington University Medical Center in 2008 and was promoted to the rank of Associate Professor of Medicine in 2014. Her early research work focused on the use of angiogenesis inhibitors, bone-targeted agents, circulating tumor cells, clinical trial design and drug development. She has served in varying capacities as a peer reviewer, editorial board member and expert panel for highly acclaimed journals and congressionally directed research program grants. She is a well-published author and investigator of multiple GU trials, including prostate cancer, bladder cancer and kidney cancer trials. She is a well-established educator and serves on the editorial board of various academic journals. Dr. Aragon-Ching has chaired national meetings at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium and has delivered esteemed presentations at the Society of Urologic Oncology, Best of ASCO, AUA, EAU, and the ASCO Annual meeting. She has also been previously named a “Top Doctor” by Washingtonian magazine and a “Best Doctor” by the Northern Virginia magazine. Dr. Aragon is rated as an Elite provider by MediFind in the treatment of Urothelial Cancer. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Urothelial Cancer, Bladder Cancer, Orchiectomy, and Prostatectomy.

Dr. Ramez I. Andrawis is a urologist affiliated with Sibley Memorial Hospital and George Washington University Hospital, where he is an assistant professor of urology and the director of the Urology Lab. He practices out of GW Medical Faculty Associates in Washington, D.C. Dr. Andrawis has an expertise in female urology, benign prostatic hyperplasia, urinary incontinence and reconstructive surgery. Dr. Andrawis earned his undergraduate and medical degree from the University of Cairo in Egypt, where he went on to complete a residency in urology. Dr. Andrawis also completed a residency in urology at the Royal College of Surgeons in Ireland, a general surgery residency at New Britain General Hospital and a urology residency at George Washington University Hospital. Dr. Andrawis has been named a Top Doctor in the Washington, D.C. and Washington-Baltimore areas by Castle Connolly. Dr. Andrawis has contributed to numerous publications on urology. Dr. Andrawis is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Bilateral Hydronephrosis, and Ureteroscopy. Dr. Andrawis is board certified in American Board Of Urology.

Ross Krasnow is a Urologist practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 17 years. Dr. Krasnow is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Clear Cell Sarcoma, Nephrectomy, and Cystectomy.

Justin O. Benabdallah, M.D., is a urologist at Sibley Memorial Hospital, as well as an assistant professor of urology with the Brady Urological Institute and Department of Urology at Johns Hopkins Medicine. Dr. Benabdallah’s uses minimally invasive and robotic surgery techniques in the treatment of prostate and kidney cancer and has expertise in endourology for the treatment of kidney stones. He also specializes in men’s health, including erectile dysfunction, male infertility, vasectomy and enlarged prostate. Dr. Benabdallah earned his medical degree from Virginia Commonwealth University School of Medicine. He completed an internship and residency in urology at the Medical College of Wisconsin. Dr. Benabdallah also completed a fellowship in endourology and minimally invasive urology at Washington University School of Medicine in St. Louis, Missouri, where he served as a clinical instructor in urology. Dr. Benabdallah is a member of the American Urologic Society and the Endourology Society. Dr. Benabdallah earned the Dr. Anna Smither Award for Neurourology Research and the Housestaff Research Award from the Medical College of Wisconsin. Dr. Benabdallah has contributed to numerous publications and presentations on topics of urology. LinkedIn https://www.linkedin.com/in/justin-benabdallah-b827b3131 Videos Justin Benabdallah, M.D. Recent News Articles and Media Coverage Physicians taking the lead during 'Movember'. Fox 6 News. 11/30/2012. Dr. Benabdallah is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, UPJ Obstruction, Ureteroscopy, and Nephrectomy. Dr. Benabdallah is board certified in American Board Of Urology.

Dr. Patrick Mufarrij is a member of the Johns Hopkins Brady Urologic Institute at Sibley Memorial Hospital and is an expert in endourology, including percutaneous and endoscopic urologic surgery; metabolic stone and causes of the recurrent stone formation; and robotic surgery for the reconstruction of the urinary tract. He also serves as the Division Cheif for Urology at Sibley Memorial Hospital. Dr. Mufarrij earned his undergraduate degree and his medical degree from Georgetown University School of Medicine. He completed residencies in general surgery and urology at New York University School of Medicine, followed by special training in endourology during a fellowship at Wake Forest Baptist Medical Center. During his fellowship, Dr. Mufarrij focused on metabolic kidney stone disease, surgery for complex kidney stones, percutaneous renal surgery and robotic surgery. Dr. Mufarrij is a member of the American Urological Association. Dr. Mufarrij has contributed to numerous publications on the topics of urology. Dr. Mufarrij is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Kidney Stones, Perirenal Abscess, Carbuncle, Ureteroscopy, and Lithotripsy. Dr. Mufarrij is board certified in American Board Of Urology.

Dr. Channing J. Paller is a medical oncologist at Sibley Memorial Hospital and a professor of oncology at the Johns Hopkins University School of Medicine. She practices out of the Prostate Cancer Multidisciplinary Clinic at Sibley Memorial Hospital in Washington, D.C., and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD. Dr. Paller has expertise in prostate, bladder, kidney, and testicular cancer. Dr. Paller earned her medical degree from Harvard Medical School and completed a residency in internal medicine, followed by a fellowship in hematology and oncology at Johns Hopkins University School of Medicine. In addition, Dr. Paller completed a rotation with the chief of the Investigational Drug Branch at the National Cancer Institute (NCI) Cancer Therapy Evaluation Program and a rotation with the associate director for regulatory science in the Office of Oncology Drug Products at the Food and Drug Administration. She also completed rotations at the Weizmann Institute of Israel’s Department of Biological Regulation and McCord Hospital in South Africa, where she participated in the Harvard AIDS project. In 2016, Dr. Paller was one of only five oncologists awarded the NCI Mentored Patient-Oriented Research Career Development Award. In 2015, she received the 2015 Passano Clinician Scientist Award for early-stage research that is already making a contribution to science. Earlier in her career, she was selected for both a 2011-2012 Young Investigator Award by the American Society of Clinical Oncology and for the 2011-12 Eastern Cooperative Oncology Group Paul Carbone Award. Dr. Paller is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Paller’s research focuses on evaluating new therapies for prostate cancer, particularly combination therapies that engage the immune system. She is the principal investigator on two multi-site clinical trials and was the first author on the NCI Investigational Drug Steering Committee publication, “Consensus Recommendations on the Phase I Combination Clinical Trials of the Clinical Trial Design Task Force.” Dr. Paller was the chair for the oral abstract session on genitourinary cancer at the 2015 Annual Meeting of the American Society of Clinical Oncology and she is currently funded by an NCI immunotherapy grant to look at combination therapies that link standard of care therapy with inhibition of transforming growth factor beta in prostate cancer. She is also opening trials of vitamin C with chemotherapy in prostate cancer and of mistletoe in all solid tumors. Dr. Paller is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy. Dr. Paller is board certified in American Board Of Internal Medicine.

Dr. Nicholas L. Constantinople is a urologist affiliated with Sibley Memorial Hospital and Georgetown University Hospital, where he is an assistant clinical professor of urology. He practices out of Foxhall Urology in Washington, D.C. Dr. Constantinople has an expertise in benign and malignant diseases of the prostate, as well as kidney stone disease, urinary tract infections and voiding abnormalities. Dr. Constantinople earned his medical degree from Georgetown University School of Medicine. He completed a residency in general surgery at Vanderbilt University Hospital, followed by a fellowship in urology at Brigham and Women’s Hospital. Dr. Constantinople was chief of the urology department at Sibley Memorial Hospital from 2000 to 2005. Dr. Constantinople is a fellow of the American College of Surgeons and the American Urological Association. He regularly volunteers for the Community for Creative Nonviolence Homeless Shelter in Washington, D.C. Dr. Constantinople has been named a Super Doctor by the Washington Post Magazine, a Top Doctor by Consumers’ Checkbook Magazine, and a Regional Top Doctor in the Washington, D.C. and Washington-Baltimore areas by Castle Connolly. Dr. Constantinople is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Enlarged Prostate (BPH), and Prostate Cancer. Dr. Constantinople is board certified in American Board Of Urology.

Dr. Edward F. Dunne is the chief of urology at Sibley Memorial Hospital, as well as a member of the clinical staff at Georgetown University. He practices out of Foxhall Urology in Washington, D.C. Dr. Dunne also performs outpatient surgery at Massachusetts Avenue Surgery Center. Dr. Dunne has an expertise in urologic oncology and complicated stone diseases. Dr. Dunne earned his medical degree from Georgetown University School of Medicine. He completed general surgery and urology residencies at Georgetown University Hospital, where he was chief resident, had the opportunity to treat kidney stone patients with one of the first lithotripsy machines in the United States, authored a chapter on urologic surgery in a major surgical textbook and received a research grant for prostate cancer. Dr. Dunne also completed his urology fellowship at Georgetown University Hospital. He went on to work as the chief of urology and chief of surgery at Sarasota Memorial Hospital. Dr. Dunne has been repeatedly named a Top MD by Washingtonian Magazine, as well as a Top MD by Consumers’ Checkbook Magazine. Dr. Dunne is a fellow of the American College of Surgeons and a member of the American Urology Association, the American Medical Society and the D.C. Medical Society. Dr. Dunne has been involved in various research studies and contributed to numerous publications regarding urological disease. Dr. Dunne is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Enlarged Prostate (BPH), Ureteroscopy, and Prostatectomy. Dr. Dunne is board certified in American Board Of Urology.

Dr. Abhishek Srinivas received his medical degree from the Johns Hopkins School of Medicine in 2006. He completed his diagnostic radiology residency at the Montefiore Medical Center of the Albert Einstein College of Medicine in New York in 2011. This was followed by a fellowship in Vascular and Interventional Radiology at the Johns Hopkins University School of Medicine in 2012. Prior to joining Johns Hopkins as faculty, Dr. Srinivas established an interventional oncology practice serving much of central New Jersey, and a local hub for patients affiliated with Hahnemann University Hospital’s liver transplant program in Philadelphia. During this time, Dr. Srinivas was also part of the neuroradiology team for the hospital’s stroke center. His primary areas of expertise include interventional oncology (liver, kidney and bone cancers), vascular disease (deep vein thrombosis, pulmonary embolism, aneurysm treatment), uterine fibroid embolization, spine interventions, and advanced biliary interventions. Other interests include novel device evaluation and development. Videos Abhishek Srinivas, M.D. Selected Publications Chang SW, Srinivas A, Murphy KP. Chapter 5: Endovascular Management of a Patient After SAH. Bhardwaj A, Alkayed NJ, Kirsch JR, et al. Acute Stroke: Bench to Bedside. Chapter 5, 53 – 61. New York: Marcel Dekker. Copyright 2007, informa Healthcare USA inc. Farinhas, J, Srinivas A, Gulko E, Bello J. Chapter 4: Imaging of the Spine and Spinal Cord. Kirshblum S, Campagnolo D, DeLisa JA, Spinal Cord Medicine 2nd Edition. Lippincott, Williams, & Wilkins (Copyright 2011) Gailloud P, Srinivas A, Chang SW, Murphy KP. Morgan RH. Percutaneous Vertebroplasty in a Sitting Patient. Journal of Vascular and Interventional Radiology. 2005 Nov; 16(11):1558-9 Mahadevia AA, Weiland D, Kvamme P, Murphy KP, Srinivas A, Wyse G. Polymethylmethacrylate contact dermatitis after vertebroplasty. Journal of Vascular and Interventional Radiology 2007 Apr;18(4):585 Srinivas A, Chang SW, Gailloud P. Chapter 33: Diagnosis and Treatment of Cerebral Arteriovenous Malformations. Bhardwaj A, Alkayed NJ, Kirsch JR, et al. Acute Stroke: Bench to Bedside. Chapter 33, 397 – 404. New York: Marcel Dekker. Copyright 2007, informa Healthcare USA inc. Dr. Srinivas is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Bile Duct Obstruction, Ascites, Jaundice, Liver Embolization, and Bone Graft. Dr. Srinivas is board certified in American Board Of Radiology.

Mark Goldstein is a Hematologist Oncology provider practicing medicine in Bethesda, Maryland. Dr. Goldstein is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Anal Cancer, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma. Dr. Goldstein is board certified in American Board Of Internal Medicine.

Dr. Kathleen Sterling is part of the Suburban Hospital’s medical staff and a urologist with Urological Consultants, P.A. Dr. Sterling served as chief resident of the University of Maryland Medical Center urology program. During her training, she performed laboratory research related to overactive bladder. With an undergraduate degree from Vanderbilt University, Dr. Sterling served as a Surface Warfare Officer in the United States Navy, completing two deployments at sea, including one combat mission during Operation Iraqi Freedom. Dr. Sterling treats both men and women. Her expertise includes voiding dysfunction, male and female urinary incontinence and female pelvic floor disorders. Dr. Sterling’s practice also encompasses medical and surgical management of kidney stones, erectile dysfunction and urological cancers. Dr. Sterling sees patients in Bethesda and Germantown, Maryland. For appointments, call 301-530-1700. Dr. Sterling is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Urinary Incontinence, Kidney Stones, and Ureteroscopy. Dr. Sterling is board certified in American Board Of Urology.

Ryan Andrew is a Urologist practicing medicine in Washington, Washington, D.c.. Dr. Andrew is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Non-Muscle Invasive Bladder Cancer, Ureteroscopy, and Nephrectomy.

John Losee is a Urologist practicing medicine in Washington, Washington, D.c.. Dr. Losee is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Enlarged Prostate (BPH), Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Erectile Dysfunction (ED), and Ureteroscopy.

Mohit Gupta is an Oncologist practicing medicine in Washington, Washington, D.c.. Dr. Gupta is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Ureteroscopy, and Reconstructive Urology Surgery.

Michael Whalen is an Oncologist practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 18 years. Dr. Whalen is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Bladder Cancer, Reconstructive Urology Surgery, and Ureteroscopy.

Harold Frazier is a Urologist practicing medicine in Washington, Washington, D.c.. Dr. Frazier is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Reconstructive Urology Surgery, and Hernia Surgery.